Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S2352-3026(20)30186-1 http://scihub22266oqcxt.onion/10.1016/S2352-3026(20)30186-1 32628911!7333996!32628911     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lancet+Haematol 2020 ; 7 (10): e756-e764 Nephropedia Template TP {{tp|p=32628911|t=2020. Effects of the COVID-19 pandemic on supply and use of blood for transfusion |pdf=|usr=}}{{32628911}} gab.com Text Effects of the COVID-19 pandemic on supply and use of blood for transfusion JO: Lancet Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32628911 #FOAvip The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain-from donor, through collection and processing, to patients-to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic. Twit Text FOAVip Effects of the COVID-19 pandemic on supply and use of blood for transfusion ????Lancet Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32628911 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32628911 #FOAvip English Wikipedia <ref>{{Cite pmid|32628911}}</ref> Effects of the COVID-19 pandemic on supply and use of blood for transfusion #MMPMID32628911 Stanworth SJ; New HV; Apelseth TO; Brunskill S; Cardigan R; Doree C; Germain M; Goldman M; Massey E; Prati D; Shehata N; So-Osman C; Thachil J Lancet Haematol 2020[Oct]; 7 (10): e756-e764 PMID32628911show ga The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain-from donor, through collection and processing, to patients-to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic. |*Betacoronavirus[MESH] |*Blood Transfusion/statistics & numerical data[MESH] |*Coronavirus Infections/blood/complications/prevention & control/therapy[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/blood/complications/prevention & control/therapy[MESH] |Antibodies, Viral/therapeutic use[MESH] |Blood Banks/*statistics & numerical data[MESH] |Blood Coagulation Disorders/etiology/therapy[MESH] |Blood Donors/*supply & distribution[MESH] |Blood Preservation[MESH] |Blood Safety[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |Donor Selection[MESH] |Elective Surgical Procedures[MESH] |Health Care Rationing[MESH] |Health Policy[MESH] |Health Services Needs and Demand[MESH] |Hemoglobinopathies/complications/therapy[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Randomized Controlled Trials as Topic[MESH]Effects of the COVID-19 pandemic on supply and use of blood for transf(epmc).pdf DeepDyve Pubget Overpricing